share_log

Short Interest in Forbion European Acquisition Corp. (NASDAQ:FRBN) Rises By 16.7%

Financial News Live ·  Oct 18, 2022 09:12

Forbion European Acquisition Corp. (NASDAQ:FRBN – Get Rating) was the recipient of a significant growth in short interest in September. As of September 30th, there was short interest totalling 700 shares, a growth of 16.7% from the September 15th total of 600 shares. Based on an average trading volume of 18,400 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in FRBN. Saba Capital Management L.P. bought a new position in shares of Forbion European Acquisition in the first quarter worth approximately $7,842,000. TENOR CAPITAL MANAGEMENT Co. L.P. bought a new stake in Forbion European Acquisition in the first quarter valued at $3,490,000. Sculptor Capital LP bought a new stake in Forbion European Acquisition in the first quarter valued at $3,270,000. Aristeia Capital LLC bought a new stake in Forbion European Acquisition in the first quarter valued at $3,116,000. Finally, Fir Tree Capital Management LP bought a new stake in Forbion European Acquisition in the first quarter valued at $2,991,000. Institutional investors own 52.63% of the company's stock.

Get Forbion European Acquisition alerts:

Forbion European Acquisition Price Performance

FRBN stock opened at $10.10 on Tuesday. Forbion European Acquisition has a one year low of $9.86 and a one year high of $10.55. The company's 50 day moving average price is $10.07 and its two-hundred day moving average price is $10.01.

Forbion European Acquisition Company Profile

(Get Rating)

Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe.

See Also

  • Get a free copy of the StockNews.com research report on Forbion European Acquisition (FRBN)
  • Cloudflare Lights Up With 13% Gain After Wells Fargo Upgrade
  • Google, Amazon and Tesla, 3 Big Stocks Set to Move Higher
  • Biogen's Stock Pullback Offers a Second Chance
  • Pitch a Tent in Camping World Stock
  • Fisker is Entering a Critical Stage That Could Reward Investors

Receive News & Ratings for Forbion European Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forbion European Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment